BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 30246021)

  • 1. Efficacy of Ingenol Mebutate in the Treatment of Actinic Keratoses: A Pre- and Posttreatment Dermoscopic Comparative Analysis.
    Carbotti M; Coppola R; Zanframundo S; Devirgiliis V; Panasiti V
    Biomed Res Int; 2018; 2018():4381019. PubMed ID: 30246021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tracking actinic keratosis of face and scalp treated with 0.015% ingenol mebutate to identify clinical and dermoscopic predictors of treatment response.
    Pampena R; Benati E; Borsari S; Bombonato C; Lombardi M; Raucci M; Mirra M; Lallas A; Apalla Z; Papadimitriou I; Moscarella E; Kyrgidis A; Argenziano G; Pellacani G; Longo C
    J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):1461-1468. PubMed ID: 29356164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive monitoring of subclinical and clinical actinic keratosis of face and scalp under topical treatment with ingenol mebutate gel 150 mcg/g by means of reflectance confocal microscopy and optical coherence tomography: New perspectives and comparison of diagnostic techniques.
    Ruini C; Hartmann D; Bastian M; Ruzicka T; French LE; Berking C; von Braunmühl T
    J Biophotonics; 2019 Jul; 12(7):e201800391. PubMed ID: 30653833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial comparing simultaneous vs. sequential field treatment of actinic keratosis with ingenol mebutate on two separate areas of the head and body.
    Pellacani G; Peris K; Guillen C; Clonier F; Larsson T; Venkata R; Puig S
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2192-8. PubMed ID: 26300464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ingenol mebutate in actinic keratosis: a clinical, videodermoscopic and immunohistochemical study.
    Bobyr I; Campanati A; Consales V; Martina E; Molinelli E; Diotallevi F; Brisigotti V; Giangiacomi M; Ganzetti G; Giuliodori K; Offidani A
    J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):260-266. PubMed ID: 27453064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ingenol mebutate gel for actinic keratosis.
    Lebwohl M; Swanson N; Anderson LL; Melgaard A; Xu Z; Berman B
    N Engl J Med; 2012 Mar; 366(11):1010-9. PubMed ID: 22417254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-life efficacy and safety of ingenol mebutate for the treatment of actinic keratosis of the face and scalp: A single arm retrospective study.
    Ricci F; Tambone S; Neri L; Fania L; Piccioni A; Guerriero C; Fargnoli MC; Peris K
    J Dermatolog Treat; 2016 Nov; 27(6):525-530. PubMed ID: 27043050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of ingenol mebutate gel for actinic keratosis in patients in a community dermatology practice.
    Bettencourt MS
    J Drugs Dermatol; 2014 Mar; 13(3):269-73. PubMed ID: 24595570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical findings using ingenol mebutate gel to treat actinic keratoses.
    Martin G; Swanson N
    J Am Acad Dermatol; 2013 Jan; 68(1 Suppl 1):S39-48. PubMed ID: 23228305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up study of ingenol mebutate gel for the treatment of actinic keratoses.
    Lebwohl M; Shumack S; Stein Gold L; Melgaard A; Larsson T; Tyring SK
    JAMA Dermatol; 2013 Jun; 149(6):666-70. PubMed ID: 23553119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ingenol mebutate gel under maximum use conditions in large treatment areas.
    Bucko AD; Jarratt M; Stough DB; Kyhl L; Villumsen J; Hall A
    J Dermatolog Treat; 2018 Feb; 29(1):74-79. PubMed ID: 28524709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized split-face clinical trial analyzing daylight photodynamic therapy with methyl aminolaevulinate vs ingenol mebutate gel for the treatment of multiple actinic keratoses of the face and the scalp.
    Moggio E; Arisi M; Zane C; Calzavara-Pinton I; Calzavara-Pinton P
    Photodiagnosis Photodyn Ther; 2016 Dec; 16():161-165. PubMed ID: 27530375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced degree of irritation during a second cycle of ingenol mebutate gel 0.015% for the treatment of actinic keratosis.
    Jim On SC; Haddican M; Yaroshinsky A; Singer G; Lebwohl M
    Cutis; 2015 Jan; 95(1):47-51. PubMed ID: 25671445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of actinic keratoses and cancerization field of the face and scalp with 0.015% ingenol mebutate gel in Brazilian individuals: safety, tolerability and patients' perspectives.
    Gameiro L; Tovo LFR; Sanches Júnior JA; Aprahamian I
    An Bras Dermatol; 2019 Jul; 94(3):313-319. PubMed ID: 31365660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of ingenol mebutate 0.015% gel after cryosurgery of actinic keratosis: 12-month results.
    Berman B; Goldenberg G; Hanke CW; Tyring SK; Werschler WP; Knudsen KM; Larsson T; Swanson N
    J Drugs Dermatol; 2014 Jun; 13(6):741-7. PubMed ID: 24918567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT.
    Berman B; Nestor MS; Newburger J; Park H; Swenson N
    J Drugs Dermatol; 2014 Nov; 13(11):1353-6. PubMed ID: 25607702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ingenol mebutate gel 0.015% and 0.05%: in actinic keratosis.
    Keating GM
    Drugs; 2012 Dec; 72(18):2397-405. PubMed ID: 23231025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cost-utility analysis of ingenol mebutate gel for the treatment of actinic keratosis: a Scottish perspective.
    Tolley K; Kemmett D; Thybo S; Nasr R; Smethurst H
    Eur J Health Econ; 2016 Apr; 17(3):287-304. PubMed ID: 25795391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical Ingenol Mebutate: A New Treatment Modality for Multiple Actinic Keratoses and Field Cancerization.
    Kostovic K; Gulin SJ; Mokos ZB; Ceovic R
    Anticancer Agents Med Chem; 2017; 17(10):1304-1311. PubMed ID: 28270072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ingenol mebutate-mediated reduction in p53-positive keratinocytes in skin cancerization field directly correlates with clinical response in patients with multiple actinic keratoses.
    Grandi V; di Gennaro P; Torrigiani S; Basco L; Lastrucci I; Pimpinelli N
    J Eur Acad Dermatol Venereol; 2019 Jul; 33(7):1297-1303. PubMed ID: 30801837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.